Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo
Open Access
- 1 October 1995
- journal article
- research article
- Published by Wiley in Developmental Dynamics
- Vol. 204 (2) , 133-143
- https://doi.org/10.1002/aja.1002040204
Abstract
The aryl hydrocarbon receptor (AhR) is a ligand‐activated transcription factor with a basic region/helix‐loop‐helix (bHLH) motif. AhR has been sequenced and the functional domains defined and there is information on the formation of complexes with other peptides and interactions with DNA, although these areas continue to be investigated. AhR mediates many biological effects such as developmental toxicity, including induction of cleft palate and hydronephrosis. This regulatory protein is expressed in embryonic liver and has been immunohistochemically localized in cells of human and mouse secondary palate. The expression of AhR in embryonic tissues and its ability to disrupt development suggests a significant role for this protein in development. The present study examines the pattern of AhR expression in the C57BL/6N mouse embryo from gestation days (GD) 10–16, using in situ hybridization and immunohistochemical analysis. AhR mRNA was localized with 35S‐RNA antisense riboprobe (cAh1 probe, 1.8 Kb amino terminal DNA). AhR protein was localized with purified monoclonal antibody (RPT‐9) raised against the N‐terminal peptide sequence. AhR mRNA and protein were expressed in GD 10–13 neuroepithelium, and as development progressed the levels in brain decreased. GD 10–12 embryos also showed AhR in branchial arches, heart, somites, and liver. AhR protein and mRNA in heart were highest at GD 10–11 and decreased with age. In liver, AhR mRNA and protein levels increased and nuclear localization became more pronounced with gestational age. In GD 14–16 embryos levels in liver and adrenal were highest, but AhR was present in ectoderm, bone, and muscle. AhR expression was specific for both cell type, organ/tissue, and developmental stage, suggesting that this novel ligand‐activated transcriptional regulator may be important in normal embryonic development. © 1995 wiley‐Liss, Inc. 1 This article is a US Government work and, as such, is in the public domain in the United States of America.Keywords
This publication has 51 references indexed in Scilit:
- Interactive Regulation of Ah and Glucocorticoid Receptors in the Synergistic Induction of Cleft Palate by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and HydrocortisoneToxicology and Applied Pharmacology, 1994
- Mechanistic aspects of dioxin actionChemical Research in Toxicology, 1993
- Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palateTeratology, 1992
- Characterization of multiple forms of the Ah receptor: comparison of species and tissuesBiochemistry, 1989
- Retinoic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhance teratogenesis in C57BL/6N miceToxicology and Applied Pharmacology, 1989
- Association of the dioxin receptor with the Mr 90,000 heat shock protein: A structural kinship with the glucocorticoid receptorBiochemical and Biophysical Research Communications, 1988
- Synergistic interaction of 2,3,7,8,‐tetrachlorodibenzo‐p‐dioxin and hydrocortisone in the induction of cleft palate in miceTeratology, 1986
- 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin‐ induced cleft palate in the mouse: Evidence for alterations in palatal shelf fusionTeratogenesis, Carcinogenesis, and Mutagenesis, 1984
- 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of ToxicityAnnual Review of Pharmacology and Toxicology, 1982
- Association between the presence of the Ah receptor in embryonic murine tissues and sensitivity to TCDD‐induced cleft palateTeratogenesis, Carcinogenesis, and Mutagenesis, 1981